Abstract

Isosorbide Dinitrate 0.1% Topical Spray

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2005 - Health and Wellness

Page(s): 152

Download in electronic PDF format for $75
  • Isosorbide Dinitrate 0.1% Topical Spray Page 1

Abstract

A formulation for preparing Isosorbide Dinitrate 0.1% Topical Spray. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • vascular disorders
  • peripheral blood circulation
  • circulatory disorders
  • vasodilation
  • vasodilator
  • nitrate

Related Categories

  • FORMULATIONS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2005
Pg. 152
Isosorbide Dinitrate 0.1% Topical Spray
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Jul/Aug 2002
Pg. 255-256
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Author(s): Mason Dave
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jan/Feb 2018
Pg. 57
Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 64-68
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit
Author(s): Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M
Mar/Apr 1997
Pg. 87-89
Attention Deficit Hyperactivity Disorder
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
May/Jun 2004
Pg. 206-209
Basics of Compounding for Cold Sores or Fever Blisters
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 21-22
Methylphenidate in the Treatment of Attention Deficit Disorders
Author(s): Tenreiro Kim
Jul/Aug 2005
Pg. 275-278
Compounding for Endocrine Disorders in Adult Patients
Author(s): Grajeda Betty Jo, Vail Jane
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
May/Jun 2008
Pg. 265
Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 340
Methylprednisolone 4-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr